Epigenetic inactivation of the miR-124-1 in haematological malignancies. - Wikidata - awgldk - TriplyDB

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

http://www.wikidata.org/entity/Q31008825

about

DNA methylation and microRNA dysregulation in cancer Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.Mechanisms of resistance to decitabine in the myelodysplastic syndrome.Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma.Epigenetic alteration and microRNA dysregulation in cancer MicroRNA Methylation in Colorectal Cancer.Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126.miR-124 regulates fetal pulmonary epithelial cell maturation.Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders.Epigenetic inactivation of the MIR129-2 in hematological malignancies.MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer Mechanisms of epigenetic deregulation in lymphoid neoplasms.Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.ABCC4 is regulated by microRNA-124a and microRNA-506 Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.Epigenetic regulation of miRNA genes in acute leukemia.Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.DNA methylation of microRNA genes in multiple myeloma.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.Uncovering the DNA methylome in chronic lymphocytic leukemia.Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome.Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.

P2860

Q26998741-A99E65CE-5797-4A93-A0F0-0F28826FD9D0 Q27016561-A06FDA56-DF18-4CE0-AED1-BEF16F53AECA Q28071427-66562A65-9D78-4223-A919-FD078EE3A104 Q28296641-C9DA70D8-A47C-4AF8-8A7A-1F47A616D121 Q28545860-1D0AC2F5-BBC7-4905-81E9-1C054881B5FB Q33579391-AAD5E1FD-4961-48EB-839F-F47D10EE31E3 Q33778961-38D7DAB3-D09C-4D13-AB53-225C4B2F62AA Q33999539-5BE03DAC-1F71-4D4A-BA13-B552C9BB190F Q34259217-90020BD5-BB51-46AC-AEB1-BEDFE2C1FBA0 Q34392645-4AFF75AF-0B6D-489F-B1CA-91C2313AEF1A Q34538870-FD186844-9042-488C-AAAE-FC0EBA63C267 Q35768988-EF96FE1F-0088-4BB2-878E-6D8926E461C1 Q35911210-9D81DF79-AA67-471B-AFCC-749495BA3938 Q35959821-7E218BC5-8C85-4B51-A2FC-BA486899DE68 Q36094729-BE6E20D0-C506-45FB-A172-C179C11FBC4D Q36422143-F1182011-D7D2-4025-B808-84D6A0E6ABDB Q36621405-F51188BF-468F-480C-A694-155D2C391F06 Q36636364-85DFF891-670E-409A-9C1B-B84509F4FD96 Q36873265-4B72238E-7D1F-41C7-A5F6-03874454068F Q36920449-4ABF9A7A-5417-4DC5-BBF4-2BACCCB113BC Q37590000-2FC3C44B-1D79-4760-B803-6B1B4B82439A Q37616347-848CD083-F905-407F-A985-D70EBFED14B8 Q37694587-CE916816-BDCE-4383-8B4E-97E1C0E40CF9 Q37696142-DF0D79E9-23BE-4F8B-A58B-CB5D4AC64073 Q37965026-4FFA6C13-6EBF-423F-B50B-FE16BDC1F75E Q37973293-F8189446-B0E8-43E6-AA27-6A851075B51E Q38020153-064909F9-69B1-4D1F-848B-0FA4A2207F41 Q38059899-67AA01D5-B402-443D-B803-1F1794CA7041 Q38060723-60463E33-DE76-468C-9CF3-2F5E48D922B6 Q38074267-510B9184-0183-4C56-B21B-1B921EA64F87 Q38190971-D0C195D6-2D16-4218-8E87-0C25F29FBF2A Q38343779-567C02A6-E650-4531-AE3E-CDD76DFB981F Q38595057-9F323EF0-B925-48B1-B552-EA04A00C0FD0 Q38664137-632D91B1-7398-4583-88A2-DE282F3C07FB Q38693627-49DAAE8A-BFAB-47F8-9C4C-FE16BDE9FDA6 Q38747799-8F9DACFE-1312-4266-A30C-6AAEB3C17B5E Q38881957-644BB25F-C95E-437E-903B-62E5ABFBBB67 Q38885469-B23D02FC-99E0-498C-BC77-61CD395397C3 Q38889464-B713501A-142D-4552-A3FD-3DDEB8B552D0 Q38957493-9CD4A1B6-80F3-4B10-82DF-5D3C53D44F09

P2860

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

http://www.wikidata.org/entity/Q31008825

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@ast

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@en

type

label

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@ast

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@en

prefLabel

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@ast

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@en

P1433

Q31008825-058C10C1-65B3-4C45-970E-92C70FE4994E

P1476

Q31008825-9DB39D35-0A14-454C-8223-AADA793AF32D

P2093

Q31008825-2E5C9237-7499-4478-B036-DD382B0C13B5

Q31008825-445C6421-3A90-42E5-B09E-A794814656C3

Q31008825-4880A9AC-21B8-4FE7-AC32-9C61A5405A9E

Q31008825-7012AEFD-7F58-41D3-B11E-5C480DDC55F3

Q31008825-73ADDB19-C037-4EAC-89CE-F3505BE004EC

Q31008825-9B3F564D-47C4-4424-8A5F-57088B4C22ED

Q31008825-F3E93C85-0164-42EA-8253-6B61B37DB370

Q31008825-F9D3EB17-DF95-4866-80E8-F6577DFE2CD8

P2860

Q31008825-05BC05B3-1FF2-49CB-AF4F-F5FD1FD452A8

Q31008825-05BEC302-FA70-4215-BB22-36C1FDA019D2

Q31008825-0EB21F02-8F5C-4898-8224-D82575E65776

Q31008825-23FE22C5-A6E2-4F5B-A6F5-0B2518E73A4A

Q31008825-4C1E5051-C623-43E9-93E8-045BDD708FCA

Q31008825-52702C1A-CA79-4348-A445-855D59702850

Q31008825-5A14AE5B-03C3-42AB-A79C-7254ADA138A6

Q31008825-64548F06-12EC-441E-BADF-0EF8EEB156ED

Q31008825-68519C91-5609-4D27-9E1A-7DD9B01D1BF6

Q31008825-737A7A23-0918-4745-AA68-6EFFBA5462DF

P304

Q31008825-6E4D770D-C2F2-4307-A706-34D96CE89A0B

P31

Q31008825-8B253194-3B7C-4ED1-B20E-0D17446AD9EE

P356

Q31008825-9DD6D722-A101-4368-9F1B-DDB64AFFA7C9

P407

Q31008825-8AE7A1DB-8607-495D-A62D-44D84590C039

P433

Q31008825-17174E03-E3EB-4551-8A59-810606F7DD67

P478

Q31008825-50775DDB-DEE9-4187-9F0C-9F72EC6A8274

P50

Q31008825-B3A09781-6629-4744-923B-0C23A39722C4

P577

Q31008825-B5F754D5-E4C7-4D2B-A57E-93013E401D72

P5875

Q31008825-6A36E9B7-621A-4EF3-A788-FE3CF19D6ECC

P698

Q31008825-57D1C17A-C1EE-4F23-97F2-74E0AEF23512

P932

Q31008825-00A12D70-B078-40D0-92E3-1BCCFCBD7AA4

P356

JOURNAL.PONE.0019027

P1433

P1476

Epigenetic inactivation of the miR-124-1 in haematological malignancies.

@en

P2093

Chi Chiu So

http://www.w3.org/2001/XMLSchema#string

Chor Sang Chim

http://www.w3.org/2001/XMLSchema#string

Dong-Yan Jin

http://www.w3.org/2001/XMLSchema#string

Florence Loong

http://www.w3.org/2001/XMLSchema#string

George Kam Hop Li

http://www.w3.org/2001/XMLSchema#string

Lap Ping Chung

http://www.w3.org/2001/XMLSchema#string

Raymond Liang

http://www.w3.org/2001/XMLSchema#string

William Wai Lung Lam

http://www.w3.org/2001/XMLSchema#string

P2860

Two genetic hits (more or less) to cancer

Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Multiple myeloma

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Oncomirs - microRNAs with a role in cancer

Hypermethylation of gene promoters in hematological neoplasia

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma

Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

P304

e19027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0019027

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Kwan Yeung Wong

P577

2011-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51099856

http://www.w3.org/2001/XMLSchema#string

P698

21544199

http://www.w3.org/2001/XMLSchema#string

P932

3081325

http://www.w3.org/2001/XMLSchema#string